Cholelithiasis, Cholecystectomy, and Cancer: A Case-Control Study in Sweden
|
|
- Aubrey Harper
- 5 years ago
- Views:
Transcription
1 GASTROENTEROLOGY 1982;83:672-6 Cholelithiasis, Cholecystectomy, and Cancer: A Case-Control Study in Sweden ALBERT B. LOWENFELS, LENNART DOMELLOF, CLAS G. LINDSTROM, FRANK BERGMAN, MARY A. MONK, and NILS H. STERNBY Department of Surgery and Preventive Medicine, New York Medical College; Departments of Surgery and Pathology, Umea University, Sweden; Department of Pathology, University of Lund, Malmo General Hospital, Sweden To study the relationship between gallstone disease (cholelithiasis and cholecystectomy) and cancer, a case-control study was performed in two Swedish hospitals comparing the prevalence of gallstone disease discovered at necropsy in 1422 subjects who died of cancer and 1205 subjects who did not die of cancer. Gallstone disease was more prevalent in the group of 131 women <50 yr of age who died of various cancers: odds ratio = 2.2, P < When the analysis was restricted to 89 younger women who died of cancers that have been suggested to be related to diet (breast, reproductive system, gastrointestinal), the results became more significant: odds ratio = 3.3, P < No such relationship was detected in older women or in men of any age. It seems likely that gallstone disease and several common cancers in younger Swedish women share similar epidemiologic and perhaps metabolic features. Gallstones share similar epidemiologic features with large bowel, breast, and female reproductive cancers, and it seems reasonable that these common diseases may be related through diet. However, it has been difficult to establish this association within individual population groups, perhaps because of selection of inappropriate controls, or because the groups studied were too small to detect important subgroup differences. Received November 13,1981. Accepted April 27, Address requests for reprints to: Albert B. Lowenfels, M.D., Department of Surgery, New York Medical College, Munger Pavilion, Valhalla, New York This study was supported in part by a grant to Albert B. Lowenfels, M.D., from the University of Umea, Sweden while he was a Visiting Professor of Surgery. The authors are indebted to Sven Dahlgren for facilitating the work in Umea, Dr. Calum Muir for valuable ideas, and Stephen Shev and Gert Lindell for their help in examining the records by the American Gastroenterological Association /82/ $02.50 The objectives of this study were: (a) to look for an association between gallstone disease and large bowel cancer as suggested in several previous reports (1-3), (b) to search for an association between gallstones and other "diet" cancers as we have previously suggested (4), (c) to look particularly at the association between various cancers and gallstones in younger subjects since in a preliminary report we found a possible excess of gallstones in younger but not older subjects with cancer (5). The relationship between gallstones, cholecystectomy, and various common cancers was examined using available necropsy records of a large number of Swedish subjects. Subjects selected for study were mainly individuals who died as a result of gastrointestinal, female reproductive, or breast cancers because these tumors have been suggested to be dietrelated (6-8). We have included additional patients who died of other cancers, such as lung, kidney, brain, and malignant lymphoma, to determine whether or not the association between gallstones and cancer might be a general one. Methods The method chosen was a case-control study comparing the prevalence of gallstones or previous cholecystectomy discovered at necropsy in subjects who died of cancer and those who did not die of cancer from 1970 to We selected Sweden as a suitable country because it has a homogeneous, stable population, high quality medical records, and a strong tradition of necropsy examination for nearly every hospital death. The study was performed in two university hospitals Umea Hospital in the north of Sweden and Malmo General Hospital in the south. Umea Hospital, the sole hospital responsible for medical care for the surrounding region of 140,000 people, performed 7569 necropsies during the 10- yr study period, representing 80% of all hospital deaths. Malmo General Hospital is the only hospital supplying
2 September 1982 GALLSTONES AND CANCER 673 Table 1. Types of Tumors and Prevalence of Gallstone Disease in Subjects Fifty Years of Age or Older Men Women of sub- GSDb % of sub- GSp % Type of tumor jects present GSD jects present GSD Colorectal Stomach Breast Reprod ucti ve Lung Bladder, prostate Other si tes O Total Control subjects a Brain, kidney, thyroid, malignant lymphoma, melanoma. b GSD = Gallstone disease. general medical care for the 248,000 inhabitants of Malmo, and during the study period 14,612 necropsies were performed, representiqg 93% of all hospital deaths. Selectiop of Cancer Cases During the years , 7654 deaths from cancer were recorded for the two centers. Tables 1 and 2 list the numbers and types of cancers selected for review. In Umea we included all male and female subjects (749 cases) dying between 1970 and 1979 with any of the tumors listed in the tables. In Malmo we included all women <60 yr old and all men <50 yr old who died between 1970 and 1979 of cancers listed in Tables 1 and 2; all men and women who died of large bowel cancer between 1977 and 1979; 58 randomly selected men aged yr who died of cancers of the lung, brain, kidney, or malignant lymphoma (total Malmo cases = 673). Of the 1422 cancer subjects who were reviewed, 228 were <50 yr old and 1194 were 50 yr or older. Selection of Controls Controls were subjects who did not have cancer and who were chosen from lists in each institution that gave the year and date of death, age at death, sex, and cause of death. The most common ca4ses for death of control subjects < 50 yr old were accidents, lesions of the central nervous system, renal disease, and pulmonary disorders. Cardiovascular diseases accounted for < 10% of deaths in younger women and 31 % of deaths in younger men. In contrast, control subjects aged 50 yr and older had cardiovascular disorders such ' as myocardial infarction and stroke that accounted for the majority of deaths. Exclusions Subjects who were <20 yr old were not included in the study, nor were individuals with cancers of the gall- bladder, liver, biliary tract, and pancreas. After selection, we excluded 125 (9%) subjects who had cancer: 42 individuals with multiple tumors, 27 individuals lacking information about the gallbladder, 56 individuals who died as a result of cancer but with autopsy evidence of a disease that might increase the risk of gallstone disease such as alcoholic cirrhosis, cholecystitis, pancreatitis, or hemolytic disorders. Thirteen excluded cancer patients were < 50 yr old. One hundred fifty-seven control subjects (13%) were excluded, 48 individuals lacking information about the gallbladder and 109 subjects with diseases that might increase the risk of gallstone disease as listed above. Twenty-one excluded control subjects were <50 yr old. Matching Procedure For each cancer subject <50 yr old a control of the same sex who did not have cancer at death and who was autopsied in the same hospital was selected. Age at death was matched exactly, if possible, using a control subject who died within the same year as the cancer subject. If this was impossible, then the 3 yr preceding or following the year of death of the cancer subject were searched. If this did not result in a match, then the age range from which a matched control could be selected was expanded to include the year on either side of the age of the cancer subject. If this did not yield a match, then the acceptable age range for the control subject was expanded an addi- Table 2. Matched-Pair Comparison of Gallstone Disease in Subjects Less Than Fifty Years of Age Who Died of Cancer or of Other Causes Concordant pairs Discordant pairs Patients Controls of GSDO GSD with with Odds Type of tumor tumors present absent GSDO GSDO ratio Men Large bowel Stomach Lung Other types b All tumors Women Gr, breast, reproductive Large bowel Stomach CXl Breast Reprod ucti ve Subtotal c Lung Other types d All tumors " a GSD = Gallstone disease. b Lymphoma = 17, brain = 11, kidney = 9, genitourinary = 3, miscellaneous = 3. c X 2 = 11.26; p < 0.001; 95% confidence intervalfor odds ratio = d Lymphoma = 6, brain = 12, kidney = 3, miscellaneous = 8. e X2 = 6.94; p < 0.01; 95% confidence interval for odds ratio =
3 674 LOWENFELS ET AL. GASTROENTEROLOGY Vol. 83, No.3 tional year and the search continued, using, if necessary, control subjects from the entire study decade. In this fashion all cancer subjects <50 yr old were matched within 2 yr of age; 80% were matched for the same year. Cancer subjects aged 50 yr or older were stratified by age (decade), hospital, and sex and were then compared with a group of patients who died without cancer. In each hospital this control group was constructed by selecting every 15tp. patient who did not have cancer at death, for a total of 977 control subjects aged 50 yr or older. After selection of cases and controls, individual necropsy protocols were then inspected to determine whether or not the gallbladder was present or absent, and whether or not gallstones were present in the gallbladder or bile ducts. An absent gallbladder was presumed to indicate previous cholecystectomy; both cholelithiasis and cholecystectomy were considered indicative of gallstone disease. Statistical Methods For subjects <50 yr old we used McNemar's method to analyze discordant pairs after eliminating those pairs where gallstone disease was either present or absent in both cancer subject and control. Ninety-five percent confidence intervals for the resulting odds ratios that differed significantly from unity were calculated after first estimating the lower and upper limits for the proportion of cancer subjects with gallstone disease (9). For patients aged 50 yr and over X 2 determinations were performed comparing various categories of cancer subjects with control subjects after stratifying them by decade, sex, and hospital. Results In both institutions the records were of a very high quality so that the presence or absence of gallstone disease could be determined in 98% of the chosen cancer cases. In both cancer subjects and control subjects aged 50 yr or over, gallstone disease was extremely frequent, resembling a previous recent report from Sweden (10) (Table 1). However, when cancer subjects aged 50 yr or older were stratified by age, sex, type of tumor, and hospital, no significant differences (p > 0.10) could be found when compared with control subjects without cancer (data not shown). In both centers there were 97 men <50 yr old who died as a result of cancer who were selected for review. When compared with individually matched controls, there was no difference in the prevalence of gallstone disease as noted at necropsy: odds ratio = 0.64, X 2 = 0.70, P > 0.30 (Table 2). Cholecystectomy had been performed on 5 of the cancer subjects and 3 control subjects. There were 131 records available for women <50 yr old who died as a result of cancer between 1970 and 1979 in the two hospitals; this group of younger women showed a significant incidence of gallstone disease compared with matched noncancer controls: 52 discordant pairs, odds ratio = 2.2, X2 = 6.94, P < When we restricted the analysis to those 88 younger women who died of cancers of the gastrointestinal tract, breast, or reproductive organs, the results became highly significant: 43 discordant pairs, odds ratio = 3.3, X2 = 11.26, P < (Table 2). In contrast, there was no significant excess of gallstone disease in the group of WOmen <50 yr old who died as a result of cancer of the lung, kidney, brain, lymphoma, or miscellaneous tumors: 9 discordant pairs, odds ratio = 0.5, X2 = 0.44, P > Necropsy disclosed gallstone disease in 43 of the 131 women who died at <50 yr of age and who had cancer. In 16 individuals, cholecystectomy had been performed with an average interval of 11 yr between cholecystectomy and death from cancer. In the remaining 27 subjects, gallstones were present at necropsy. Table 3 contrasts cholecystectomy with cholelithiasis (discordant pairs only) in this group of younger women who died of cancer as compared with matched noncancer control subjects. The resulting odds ratios were similar for both cholecystectomy and cholelithiasis, but attained statistically significant levels only for cholelithiasis. Discussion The results show an association between gallstone disease and several common cancers in Swedish women <50 yr old; similar results were obtained in a smaller study conducted in the United States (5). We recognize the dangers in drawing conclusions from autopsy material. In this study, however, nearly all hospital deaths were autopsied. In addition, Table 3. Presence or Absence of Gallstone Disease in Matched Discordant Pairs of Female Subjects Less Than Fifty Years of Age Who Died of Cancer or of Other Causes; Cholecystectomy Compared With Cholelithiasis Patients Controls with with Odds Type of tumor GSD GSD ratio Cholecystectomy GI, breast, reproductive Lung, kidney, lymphoma, miscellaneous All tumors Cholelithiasis GI, breast, reproductive b Lung, kidney, lymphoma, miscellaneous All tumors " a GSD = Gallstone disease. b X 2 = 6.76; P < 0.01; 95% confidence interval = "X2 = 4.36; P < 0.05; 95% confidence interval =
4 September 1982 GALLSTONES AND CANCER 675 among women <50 yr old who died outside of hospital, more than one-half were autopsied under the medical-legal system; review of these records disclosed few cancer cases. One-fourth of the control subjects who were women <50 yr old died of accidental causes; the percentage of gallstone disease was similar to the other younger female control subjects (18% vs. 17%). There are of course other biases in an autopsy study, such as different case fatality rates for cancer subjects and controls. We believe, though, that most of these biases would have operated to underestimate the true difference in gallstone disease prevalence between cancer patients and controls. Another flaw could be closer attention to the gallbladder in autopsies of cancer subjects than of noncancer subjects. No evidence of such a bias could be detected; the records of both cancer and noncancer subjects revealed the same careful examination of the biliary tract in both groups. Observer bias in selecting and matching cancer subjects and controls might introduce an error. Again, this seems unlikely, since we reviewed a large number of cancers of every major type, including nearly all cancer subjects who died at <50 yr of age. Moreover, the status of the gallbladder was ascertained only after selecting cancer subjects and controls. In our study, the prevalence of gallstones in younger control subjects who were women was 17.6% nearly identical to the figure of 18.6% found by Lindstrom (10) in Sweden in unselected women in the same age group who died. Thus, we consider it unlikely that a significant bias has been introduced by excluding younger female control subjects who might have had gallstones or by improper selection procedures. Furthermore, if we compare the 42 younger female subjects who died of nondiet cancers to the 89 younger women who died with diet cancers, the results again show that subjects who died with diet cancers had an excess of gallstones (relative risk = 3.4, corrected x 2 = 6.28, P < 0.02). The average age of all of the younger women who died of cancer was 43.2 ± 5.0 yr; there was no difference in age in subjects who died of any of the various types of cancer. Of the 131 women who were <50 yr old, 30 died in Umea Hospital and 101 in Malmo General Hospital. These two groups were similar with respect to distribution of various types of tumors, proportion of cancer subjects and controls with gallstone disease, and average age. Furthermore, necropsy procedures at the two hospitals were comparable, including an equally detailed description of the biliary tract in both institutions. In this study, deaths from cardiovascular disease were common in male control subjects of all ages and in female control subjects >50 yr old. Gallstones are known to be more prevalent with cardiovascular disorders (11,12), perhaps explaining why we observed positive findings only in younger women. We found a positive association between cancer and gallstone disease in younger women who died of gastrointestinal, reproductive, or breast cancer-tumors that have been suggested to be diet-related. An association between gallstone disease and large bowel cancer has been observed in most (1-3), but not all (13), previous reports. Gallstone disease has been reported to be associated with female reproductive cancers (6,14) but not with breast cancer. Obesity could be a common link, since it is a major risk factor for gallstones (15) and since a greater incidence of breast and reproductive cancers have been observed in obese women (16). Duodenogastric reflux, a possible risk factor in gastric cancer, is thought to be more frequent in patients with gallstone disease (17,18); this could explain why we found a greater incidence of gallstone disease in younger women with gastric cancer. Our results imply that younger Swedish women who died as a result of gastrointestinal, breast, or reproductive tumors are 3-4 times more likely to have cholelithiasis or previous cholecystectomy than matched controls without cancer. However, because of the various problems inherent in a casecontrol study, the association we have reported between gallstones and certain tumors in younger women may be weaker than we think or may only be an apparent one. To clarify and extend these findings we have initiated a prospective study of the incidence of cancer in Sweden after cholecystectomy. References 1. Capron JP, Delamarre J, Canarelli JP, et al. La cholecystectomie favorise-t-elle l'apparition due cancer rectocolique. Gastroenterol Clin BioI 1978;2: Linos DA, Beard CM, O'Fallon WM, et al. Cholecystectomy and carcinoma of the colon. Lancet 1981;ii: Vernick LJ, Kuller LH. Cholecystectomy and right-sided colon cancer: an epidemiologic study. Lancet 1981;ii: Lowenfels AB. Gallstones and the risk of cancer. Gut 1980;21: Lowenfels AB, Schwartz R, Pitchumoni C. Cholelithiasis and cancer. Gastroenterology 1981;80: Casagrande JT, Pike MC, Ross RK, et al. Incessant ovulation and ovarian cancer. Lancet 1979;ii: Berg JW. Can nutrition explain the pattern of international epidemiology of hormone-dependent cancers? Cancer Res 1975;35: Reddy BS, Cohen LA, McCoy GD, et al. Nutrition and its relationship to cancer. Adv Cancer Res 1980;32: Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley and Sons, 1981: Lindstrom CG. Frequency of gallstone disease in a well-
5 676 LOWENFELS ET AL. GASTROENTEROLOGY Vol. 83, No.3 defined Swedish population. Scand J Gastroenterol 1977; 12: Bergman F, Van der Linden W, Soderstrom J. The connexion between myocardial infarction and gallstones in an autopsy series. Acta Pathol Microbiol Scand 1968;73: Breyfogle HS. The frequency of coexisting gallbladder and coronary artery disease: a statistical analysis and biometric evaluation of 1493 necropsies. JAMA 1940;114: Castled en WM, Doouss TW, Jennings KP, Leighton M. Gallstones, carcinoma of the colon and diverticular disease. Clin Oncol 1978;4: Mack TM, Pike Me, Henderson BE, et al. Estrogens and endometrial cancer in a retirement community. N Engl J Med 1976;294: Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man. N Engl J Med1978;299: Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979;32: Rees WEW, Rhodes J. Bile reflux in gastro-oesophageal disease. Clin GastroenteroI1977;6: Kalima T, Sjoberg J. Bile reflux after cholecystectomy. Scand J GastroenteroI1981;16(Suppl 67):153-6.
5.2 Main causes of death Brighton & Hove JSNA 2013
Why is this issue important? We need to know how many people are born and die each year and the main causes of their deaths in order to have well-functioning health s. 1 Key outcomes Mortality rate from
More informationEpidemiology in Texas 2006 Annual Report. Cancer
Epidemiology in Texas 2006 Annual Report Cancer Epidemiology in Texas 2006 Annual Report Page 94 Cancer Incidence and Mortality in Texas, 2000-2004 The Texas Department of State Health Services Texas Cancer
More informationSTEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL
MAIN OFFICE: (618) 692-7478 MORGUE: (618) 296-4525 FAX: (618) 692-6042 FAX: (618) 692-9304 STEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL. 62025-1962
More informationTable E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths
RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected
More informationTHE NATURAL COURSE OF GALLSTONE DISEASE
GASTROENTEROLOGY Copyright 1966 by The Williams & Wilkins Co. Vol. 50, 3 Printed in U.S.A. THE NATURAL COURSE OF GALLSTONE DISEASE Eleven-year review of 781 nonoperated cases ANDERS WENCKERT, M.D., AND
More informationcame from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary
Thorax 1982;37:366-370 Thoracic metastases MARY P SHEPHERD From the Thoracic Surgical Unit, Harefield Hospital, Harefield ABSTRACI One hundred and four patients are reviewed who were found to have thoracic
More informationCANCER IN NSW ABORIGINAL PEOPLES. Incidence, mortality and survival September 2012
CANCER IN NSW ABORIGINAL PEOPLES Incidence, mortality and survival September 2012 CANCER IN NSW ABORIGINAL PEOPLES Contents Tables 1 Figures 2 Message from the Chief Cancer Officer 4 Executive summary
More informationAPPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
More information*
Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The
More informationUniversity of Bristol - Explore Bristol Research
Hunt, L., Ben-Shlomo, Y., Whitehouse, M., Porter, M., & Blom, A. (2017). The Main Cause of Death Following Primary Total Hip and Knee Replacement for Osteoarthritis: A Cohort Study of 26,766 Deaths Following
More informationManagement of BRCA Positive Breast Cancer. Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH
Management of BRCA Positive Breast Cancer Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH The number of American women who have lost their lives to breast cancer outstrips the total number
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.
More informationSummary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene)
EMA/679870/2014 Summary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene) This is a summary of the risk management plan (RMP) for Duavive, which details the measures
More informationSuicides increased in 2014
Causes of death 2014 23 May, 2016 Suicides increased in 2014 Diseases of the circulatory system accounted for 30.7% of the deaths recorded in 2014, 2.4% more than in the previous year. The average age
More informationUpper Gastrointestinal Research (UGIR) Jesper Lagergren, professor of surgery Karolinska Institutet and King s Health Partners London
Upper Gastrointestinal Research (UGIR) Jesper Lagergren, professor of surgery Karolinska Institutet and King s Health Partners London UGIR SIMSAM funding in 2008 Creation of UGIR (Upper Gastro-Intestinal
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland April 2017 First published in June 2004, revised with each National Statistics publication Next due for revision October 2017 Information Services Division NHS National Services Scotland
More informationFigure 1: Consort diagram; the status of participants in the study
Figure : Consort diagram; the status of participants in the study Figure a. Time to first colorectal cancer in those randomized to aspirin compared with those randomized to aspirin placebo (AP). Kaplan-Meier
More informationCancer in the Northern Territory :
Cancer in the Northern Territory 1991 21: Incidence, mortality and survival Xiaohua Zhang John Condon Karen Dempsey Lindy Garling Acknowledgements The authors are grateful to the many people, who have
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
Appendix B: Scope NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE Post publication note: The title of this guideline changed during development. This scope was published before the guideline
More informationContraception and cancerepidemiological
Contraception and cancerepidemiological evidence Hormonal contraception Combined Progestogen-only Philip C Hannaford University of Aberdeen Breast cancer and combined oral Re-analysis of individual data
More informationCHAPTER 3 DEATHS. Stephen McDonald Leonie Excell Brian Livingston
CHAPTER 3 DEATHS Stephen McDonald Leonie Excell Brian Livingston DEATHS ANZDATA Registry 2008 Report INTRODUCTION AUSTRALIA NEW ZEALAND The total number of deaths was 1,452 (15.4 deaths per 100 patient
More informationAll Discovered Death Outcome Detail (Form 124/120)
This file includes all reported deaths regardless of consent. ID WHI Common ID Col#1 DEATHALL All Discovered Death Col#2 Any report of death, regardless of consent status. 0 No 106,931 66.1 1 Yes 54,877
More informationOutcomes Report: Accountability Measures and Quality Improvements
Outcomes Report: Accountability Measures and Quality Improvements The s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures. Because we are an accredited
More informationImpact and implications of Cancer Death Status Reporting Delay on Population- Based Relative Survival Analysis with Presumed-Alive Assumption
Impact and implications of Cancer Death Status Reporting Delay on Population- Based Relative Survival Analysis with Presumed-Alive Assumption X Dong, Y Ren, R Wilson, and K Zhang NAACCR 6-20-2017 Introduction
More informationCancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer
Cancer in Ontario 1 in 2 Ontarians will develop cancer in their lifetime 1 in 4 Ontarians will die from cancer 14 ONTARIO CANCER STATISTICS 2016 1 Cancer in Ontario An overview Cancer is a group of more
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland April 2013 First published in June 2004, revised with each National Statistics publication Next due for revision October 2013 Information Services Division NHS National Services Scotland
More informationGastrointestinal Diverticulosis A Retrospective Analysis
Abstract Gastrointestinal Diverticulosis A Retrospective Analysis Pages with reference to book, From 14 To 19 Huma Qureshi, Sarwar J. Zuberi ( PMRC Research Centre, Jinnah Postgraduate Medical Centre,
More informationRed meat consumption and long-term cancer risk Alicja Wolk
Red meat consumption and long-term cancer risk Alicja Wolk Professor of Nutritional Epidemiology Institute of Environmental Medicine Karolinska Institutet WCRF/AICR report 2007 Food, Nutrition, Physical
More informationGastroenterology. Certification Examination Blueprint. Purpose of the exam
Gastroenterology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified gastroenterologist
More informationS2 File. Clinical Classifications Software (CCS). The CCS is a
S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous
More informationSupplementary Online Content
Supplementary Online Content Henson KE, Brock R, Charnock J, Wickramasinghe B, Will O, Pitman A. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry. Published online November 21, 2018.
More informationBiliary MRI w Eovist
Biliary MRI w Eovist Is there any added value? Elmar M. Merkle, MD Director of MR Imaging Duke University Medical Center elmar.merkle@duke.edu Declaration of Conflict of Interest or Relationship Research
More informationALL CANCER (EXCLUDING NMSC)
ALL CANCER (EXCLUDING NMSC) AVERAGE NUMBER OF CASES PER YEAR (2011-2015) AVERAGE NUMBER OF DEATHS PER YEAR (2011-2015) Male Female Both sexes Male Female Both sexes 4,557 4,516 9,073 1 2,196 1,984 4,180
More informationRisk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE
Identifying the Patient at Risk for an Inherited Syndrome Sapna Syngal, MD, MPH, FACG Director, Gastroenterology Director, Familial GI Program Dana-Farber/Brigham and Women s Cancer Center Associate Professor
More informationArteriovenostomy for renal dialysis 39.27, 39.42
Surgery categories NHSN Surgery codes (Reference: NHSN Operative Procedure Category Mappings to ICD-9-CM Codes, October 2010 www.cdc.gov/nhsn/pdfs/pscmanual/9pscssicurrent.pdf) Operative aortic aneurysm
More informationOverview of 2009 Hong Kong Cancer Statistics
Overview of 2009 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since 1963 been providing population-based cancer data for epidemiological research and healthcare
More informationGYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer
GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer Causes of Hereditary Ovarian and Uterine Cancer uterine cancer ovarian cancer Sporadic 75-90% Sporadic 70-80% Hereditary, 5% Lynch syndrome
More informationALL CANCER (EXCLUDING NMSC)
ALL CANCER (EXCLUDING NMSC) AVERAGE NUMBER OF CASES PER YEAR (2012-2016) AVERAGE NUMBER OF DEATHS PER YEAR (2012-2016) Male Female Both sexes Male Female Both sexes 4,607 4,632 9,240 1 2,238 2,036 4,274
More informationAre you at risk of Hereditary Cancer? Your Guide to the Answers
Are you at risk of Hereditary Cancer? Your Guide to the Answers What is Hereditary Cancer? The genes we are born with may contribute to our risk of developing certain types of cancer, including breast,
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Comparative Study between Laparoscopic and Open Cholecystectomy for Dr. B. Hemasankararao 1,
More informationOverview of 2013 Hong Kong Cancer Statistics
Overview of 2013 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry (HKCaR) is a population-based cancer registry, collecting the basic demographic data, information
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland October 2012 First published in June 2004, revised with each National Statistics publication Next due for revision April 2013 Information Services Division NHS National Services Scotland
More informationA Closer Look at Leading Causes of Death in Guilford County
2015 GCDHHS Division of Public Health Data Brief A Closer Look at Leading Causes of Death in Guilford County Highlights Heart disease mortality rates declined 43% from 244.8 deaths per 100,000 in 1995
More informationEvaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials
Evaluation of Ancestry Information Markers (AIMs) from Previous ACOSOG/CALGB/NCCTG Trials Mary Beth Terry, PhD Department of Epidemiology Mailman School of Public Health Racial and Ethnic Disparities in
More informationPostmenopausal hormone therapy and cancer risk
International Congress Series 1279 (2005) 133 140 www.ics-elsevier.com Postmenopausal hormone therapy and cancer risk P. Kenemans*, R.A. Verstraeten, R.H.M. Verheijen Department of Obstetrics and Gynaecology,
More informationSupplementary Online Content
Supplementary Online Content Chacón MR, Enrico DH, Burton J, Waisberg FD, Videla VM. Incidence of placebo adverse events in randomized clinical trials of targeted and immunotherapy cancer drugs in the
More informationSTEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL
MAIN OFFICE: (618) 692-7478 MORGUE: (618) 296-4525 FAX: (618) 692-6042 FAX: (618) 692-9304 STEPHEN P. NONN OFFICE OF THE CORONER MADISON COUNTY, ILLINOIS 157 MAIN STREET SUITE 354 EDWARDSVILLE, IL. 62025-1962
More informationUK Biobank. Death and Cancer Outcomes Report. September
UK Biobank Death and Cancer Outcomes Report September 2016 http://www.ukbiobank.ac.uk/ 1 Contents 1. Introduction...... 2 2. Data on deaths Figure 2.1: Numbers of the 20 most common causes of death.........
More informationTHE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA
THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA Presented by: Bryan Rettig, MS Nebraska Dept. of Health & Human Services Division of Public Health May 31, 2017 Nebraska Cancer Registry
More informationAssociation between cholecystectomy for gallstone disease and risk factors for cardiovascular disease
ORIGINAL ARTICLE Cholecystectomy and cardiovascular disease., 2012; 11 (1): 85-89 January-February, Vol. 11 No.1, 2012: 85-89 85 Association between cholecystectomy for gallstone disease and risk factors
More informationSelected tables standardised to Segi population
Selected tables standardised to Segi population LIST OF TABLES Table 4.2S: Selected causes of death, all-ages, 2000 2004 (Segi Standard) Table 5.3S: Public hospitalisations by major cause of admission
More informationMalignancy in relatives of patients with coeliac disease
Brit. J. prev. soc. Med. (1976), 30, 17-21 Malignancy in relatives of patients with coeliac disease P. L. STOKES, PATRICIA PRIOR, T. M. SORAHAN, R. J. McWALTER* J. A. H. WATERHOUSE, AND W. T. COOKE The
More informationPancreat ic Cancer UK. policy briefing. A cancer of unmet need: the pancreatic cancer research challenge
Pancreat ic Cancer UK policy briefing A cancer of unmet need: the pancreatic cancer research challenge Introduction Pancreatic Cancer UK s Study for Survival, launched in 2011, marked the first ever comprehensive
More informationCancer prevalence. Chapter 7
Chapter 7 Cancer prevalence Prevalence measures the number of people diagnosed with cancer who are still alive. This chapter presents current and historical statistics on cancer prevalence in Ontario.
More informationTitle: Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study
Author's response to reviews Title: Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study Authors: Michael Manz (michael.manz@claraspital.ch) Emanuel
More informationCANCER INCIDENCE AND SURVIVAL STATISTICS FOR NORTHERN IRELAND
12 March 2019 CANCER INCIDENCE AND SURVIVAL STATISTICS FOR NORTHERN IRELAND 1993-2017 Official Statistics on cancers diagnosed in Northern Ireland during 1993-2017 were published today. This release provides
More informationThe Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012
The Cancer Burden in California Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012 Goals Introduce you to the California Cancer Registry (CCR) Provide an
More informationInformation for You and Your Family
Information for You and Your Family What is Prevention? Cancer prevention is action taken to lower the chance of getting cancer. In 2017, more than 1.6 million people will be diagnosed with cancer in the
More informationOncology 101. Cancer Basics
Oncology 101 Cancer Basics What Will You Learn? What is Cancer and How Does It Develop? Cancer Diagnosis and Staging Cancer Treatment What is Cancer? Cancer is a group of more than 100 different diseases
More informationFAMILIAL CARCINOID TUMORS AND SUBSEQUENT CANCERS: A NATION-WIDE EPIDEMIOLOGIC STUDY FROM SWEDEN
Int. J. Cancer: 94, 444 448 (2001) 2001 Wiley-Liss, Inc. FAMILIAL CARCINOID TUMORS AND SUBSEQUENT CANCERS: A NATION-WIDE EPIDEMIOLOGIC STUDY FROM SWEDEN Kari HEMMINKI* and Xinjun LI Department of Biosciences
More informationClinical indications for positron emission tomography
Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will
More informationCase Report Contrast Enhanced Ultrasound of a Gallbladder Lesion in a Patient with a History of Renal Cell and Rectal Cancer
Case Reports in Gastrointestinal Medicine Volume 2013, Article ID 538534, 4 pages http://dx.doi.org/10.1155/2013/538534 Case Report Contrast Enhanced Ultrasound of a Gallbladder Lesion in a Patient with
More informationGallstones Information Leaflet THE DIGESTIVE SYSTEM. Gutscharity.org.uk
THE DIGESTIVE SYSTEM http://healthfavo.com/digestive-system-for-kids.html This factsheet is about gallstones Gall is an old-fashioned word for bile, a liquid made in the liver and stored in the gall bladder
More informationOffice of the Chief Medical Examiner Persons Present
Office of the Chief Medical Examiner CB # 7580 Chapel Hill, NC 27599-7580 Telephone 9199662253 REPORT OF AUTOPSY EXAMINATION DECEDENT Document Identifier B200901668 Autopsy Type ME Autopsy Name John Walter
More informationTopics for discussion. Pediatric General Surgery. Physiology. Surgical Newborns. Neonatal Intestinal Obstruction
Topics for discussion Pediatric General Surgery Professor General & Thoracic Surgery What makes Pediatric Surgery unique? Neonatal intestinal obstruction Abdominal wall defects Inguinal hernias Appendicitis
More informationAppendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound
EFSUMB Newsletter 87 Examinations should encompass the full range of pathological conditions listed below A log book listing the types of examinations undertaken should be kept Training should usually
More informationCancer in Maine: Using Data to Direct Actions 2018 Challenge Cancer Conference May 1, 2018
Cancer in Maine: Using Data to Direct Actions 2018 Challenge Cancer Conference May 1, 2018 Tim Cowan, MSPH Director, Data Reporting and Evaluation Center for Health Improvement MaineHealth All Cancer Mortality
More informationThe Role of Obesity and Diabetes in Cancer JOEL RUSH MS RD CSO LD CNSC FAND UT M. D. ANDERSON CANCER CENTER HOUSTON TEXAS
The Role of Obesity and Diabetes in Cancer JOEL RUSH MS RD CSO LD CNSC FAND UT M. D. ANDERSON CANCER CENTER HOUSTON TEXAS Objectives Differentiate between modifiable cancer risk factors and non-modifiable
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association What proportion of cancer is due to obesity? Tony Blakely, Diana Sarfati, Caroline Shaw The evidence linking overweight and
More informationUNC Cancer Epidemiology Seminar: Cancer Risk in New Users of Overactive Bladder Drugs
February 19, 2016 UNC Cancer Epidemiology Seminar: Cancer Risk in New Users of Overactive Bladder Drugs James A. Kaye, MD, DrPH Senior Director, Epidemiology, RTI Health Solutions Collaborators: Andrea
More informationPrevalence of Hypothyroidism in Cholelithiasis Patients in Bikaner, Rajasthan (India)
Prevalence of Hypothyroidism in Cholelithiasis Patients in Bikaner, Rajasthan (India) Original Research Article Kedar Nath 1, Ashok Kumar 2, Jitendra Acharya 3 1Senior Specialist, 2 CAS PG Resident, Department
More informationGYNplus. genetic testing for hereditary ovarian and/or uterine cancer
GYNplus genetic testing for hereditary ovarian and/or uterine cancer What Are the Causes of Hereditary Ovarian and Uterine Cancer? uterine cancer ovarian cancer sporadic 70-80% hereditary 5% Lynch syndrome
More informationConcentration and choice in the provision of hospital services: summary report NHS Centre for Reviews and Dissemination
Concentration and choice in the provision of hospital services: summary report NHS Centre for Reviews and Dissemination Authors' objectives To undertake systematic reviews of the literature on the relationship
More informationFACULTY MEMBERSHIP APPLICATION Tulane Cancer Center
FACULTY MEMBERSHIP APPLICATION Tulane Cancer Center 1430 Tulane Ave., Box SL-68, New Orleans, LA 70112-2699 J. Bennett Johnston Building, Mezzanine (Floor 1A), Suite A102 (504) 988-6060, fax (504) 988-6077,
More information2018 Texas Cancer Registry Annual Report
2018 Texas Cancer Registry Annual Report As Required by Texas Health and Safety Code Section 82.007 November 2018 Table of Contents Executive Summary... 1 1. Introduction... 2 2. Background... 3 Cancer
More informationConnecting Links for Reducing Risks: Understanding the impact of obesity on cancer development. Kristi Acker, DNP, FNP-BC, AOCNP, ACHPN
Connecting Links for Reducing Risks: Understanding the impact of obesity on cancer development Kristi Acker, DNP, FNP-BC, AOCNP, ACHPN Objectives 1) Identify factors that contribute to the financial burden
More informationAmerican Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013
American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013 All ages Younger than 45 45 and Older Younger than 65 65 and Older All sites, men 306,920 9,370 297,550 95,980 210,940 All sites,
More informationWhat All of Us Should Know About Cancer and Genetics
What All of Us Should Know About Cancer and Genetics Beth A. Pletcher, MD, FAAP, FACMG Associate Professor of Pediatrics UMDNJ- New Jersey Medical School Disclosures I have no relevant financial relationships
More informationCancer in Utah: An Overview of Cancer Incidence and Mortality from
Cancer in Utah: An Overview of Cancer Incidence and Mortality from 1973-2010 A publication of the Utah Cancer Registry January 2014 Prepared by: C. Janna Harrell, MS Senior Research Analyst Kimberly A.
More informationCancer in New Mexico 2014
Cancer in New Mexico 2014 Please contact us! Phone: 505-272-5541 E-Mail: info@nmtr.unm.edu http://som.unm.edu/nmtr/ TABLE OF CONTENTS Introduction... 1 New Cases of Cancer: Estimated Number of New Cancer
More informationEstimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004
MCSS Epidemiology Report 04:2 Suggested citation Perkins C, Bushhouse S.. Minnesota Cancer Surveillance System. Minneapolis, MN, http://www.health.state.mn.us/divs/hpcd/ cdee/mcss),. 1 Background Cancer
More informationControversies in the management of acute pancreatitis
Kathmandu University Medical Journal (3) Vol., No. 3, Issue 7, 3-7 Controversies in the management of acute pancreatitis Singh DR 1, Mehta A, Dangol UMS 3 1 Lecturer, Medical Officer, 3 Lecturer, Dept.
More informationCancer in Halton. Halton Region Cancer Incidence and Mortality Report
Cancer in Halton Halton Region Cancer Incidence and Mortality Report 2008 2012 The Regional Municipality of Halton March 2017 Reference: Halton Region Health Department, Cancer in Halton: Halton Region
More informationThe clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.
The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. Please note that the results reported in any single trial may not reflect the overall
More informationOntario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation
Ontario s Referral and Listing Criteria for Adult Pancreas-After- Kidney Transplantation Version 2.0 Trillium Gift of Life Network Adult Pancreas-After-Kidney Transplantation Referral & Listing Criteria
More informationIntensity: 0-10 (10 is the worse pain you have ever experienced in your life that you would want to jump from a building, 0 is no pain)
Patient Questionnaire: Name: Date: Occupation: Date of Birth: Age: Sex: Male Female Referring Physician: Chief Complaint: Describe your Pain: sudden onset gradual constant intermittent worsening improving
More informationExamining missing data and chance variation in public reporting of cancer stage at diagnosis. Supporting cancer data indicator development and use
Examining missing data and chance variation in public reporting of cancer stage at diagnosis Supporting cancer data indicator development and use Matthew Barclay, Georgios Lyratzopoulos, David Greenberg,
More informationThe burden of gallstone disease in Europe
Aliment Pharmacol Ther 2003; 18 (Suppl. 3): 49 53. doi: 10.1046/j.0953-0673.2003.01721.x The burden of gallstone disease in Europe R. AERTS & F. PENNINCKX Department of Abdominal Surgery, University Clinic
More informationHu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).
Appendix Definitions of Index Admission and Readmission Definitions of index admission and readmission follow CMS hospital-wide all-cause unplanned readmission (HWR) measure as far as data are available.
More informationCANCER FACTS & FIGURES For African Americans
CANCER FACTS & FIGURES For African Americans Pennsylvania, 2006 Pennsylvania Cancer Registry Bureau of Health Statistics and Research Contents Data Hightlights...1 Pennsylvania and U.S. Comparison...5
More informationThe table below presents the summary of observed geographic variation for incidence and survival by type of cancer and gender.
Results and Maps Overview When disparities in cancer incidence and survival are evident, there are a number of potential explanations, including but not restricted to differences in environmental risk
More informationEffects of dietary supplements in young and aged rats
Effects of dietary supplements in young and aged rats Drs. Magnuson and Malik University of Maryland Drs. Franke-Carroll, Hines & Alam FDA Background Estimated that 40% of US population uses dietary supplements
More informationGastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors
Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors Jaume Capdevila, MD, PhD Vall d'hebron University Hospital Vall d'hebron Institute of Oncology (VHIO)
More informationSmoking and Mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC)
Smoking and Mortality SECTION 6 Smoking and Mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC) Kotaro Ozasa Abstract In the JACC study, risk of death with all cancers and
More informationOverview of Hong Kong Cancer Statistics of 2015
Overview of Hong Kong Cancer Statistics of 2015 This report summarizes the key cancer statistics of Hong Kong for the year of 2015, which is now available on the website of Hong Kong Cancer Registry. Cancer
More informationCANCER IN TASMANIA INCIDENCE AND MORTALITY 1996
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 Menzies Centre For Population Health Research Editors: Dace Shugg, Terence Dwyer and Leigh Blizzard Publication
More informationClinical and Nutritional Study on Gallstone. Disease in Japan. Haruo Kameda, MD, Fumitake Ishihara, MD, Koji Shibata, MDand Eiichi Tsukie, MD
Original Article Clinical and Nutritional Study on Gallstone Haruo Kameda, MD, Fumitake Ishihara, MD, Koji Shibata, MDand Eiichi Tsukie, MD The dietary factors, as a cause on increasing incidence of gallstones
More informationIndian Journal of Medical Research and Pharmaceutical Sciences July 2017;4(7) ISSN: ISSN: DOI: /zenodo Impact Factor: 3.
GALLBLADDER DISEASES ASSOCIATED WITH LAPAROSCOPIC SLEEVE GASTRECTOMY IN JORDAN, PILOT STUDY Dr. Osama T. Abu Salem*, Dr. Ibrahim Al Gwairy, Dr. Ramadan Al Hasanat & Dr. Talal Jalabneh** *Consultant Gneral
More informationCancer projections National Cancer Registry
Cancer projections 25-235 National Cancer Registry Published by the National Cancer Registry 28 Building 68, Cork Airport Business Park, Kinsale Road, Cork, Ireland Telephone 21-431814 Email Web site info@ncri.ie
More informationHepatobiliary and Pancreatic Malignancies
Hepatobiliary and Pancreatic Malignancies Gareth Eeson MD MSc FRCSC Surgical Oncologist and General Surgeon Kelowna General Hospital Interior Health Consultant, Surgical Oncology BC Cancer Agency Centre
More information